TANGANIL 500 mg/5 ml, solution for injection i.v. in an ampoule 5 ampoules of 5 ml
Active ingredients: ACÉTYLLEUCINE
Commercialized according to BDPM
Solution for injection5 ampoules of 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TANGANIL 500 mg/5 ml, solution injectable I.V. en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 5 ampoule(s) en verre de 5 ml
- Marketing authorisation holder
- PIERRE FABRE MEDICAMENT
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Sept 1986
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63358726CIP73272259CIP133400932722594Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACÉTYLLEUCINEsolution | 500 mg · une ampoule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.